PF-08046040 is under clinical development by Pfizer and currently in Phase I for Relapsed Acute Myeloid Leukemia.

Amitava Chatterjee, the new CEO of Jammu Kashmir Bank , faces a set of challenges in getting the builder of JK economy back ...